Publications
3 publications
Funding
3 grants
Active
3 grants- KPUM1AI179699-01Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) ConsortiumNational Institute of Allergy and Infectious Diseases · 2024–2029 · via University of California, San Francisco
- KPBMGF INV-055896Conditional Mtb knockdown mutants for TB drug discoveryBill & Melinda Gates Foundation · 2023–2026
- KPR01AI161013-01Harnessing B Cells For TB Vaccine Development To Improve Therapy Of TB And TB-HIV CoinfectionNational Institute of Allergy and Infectious Diseases · 2021–2026 · via Center for Discovery and Innovation